Tuesday, August 17, 2010 3:14:48 PM
by Andy Obermueller, editor Fast-Track Millionaire
iCAD (NASDAQ: ICAD), the leader in computer-assisted detection of cancer and a Fast-Track Millionaire portfolio holding, announced that the FDA has cleared VeraLook, its virtual colonoscopy product.
VeraLook uses sophisticated technology to identify polyps in between 1,200 and 1,500 images produced from a non-invasive CT scan.
Though the timing was never certain, the FDA's move, which followed European approval last year, was expected.
The virtual procedure is safer, more accurate, does not require sedation and is in general far more comfortable than a traditional optical colonoscopy. VeraLook also has been shown to generate far less frequent false positives.
iCAD chief executive Ken Ferry said 40 million Americans who should have colonoscopies do not get them and said iCAD's break-through technology could prompt more people to undergo the examination.
As with all forms of cancer, early detection is the key to successful treatment. The American Cancer Society says colorectal cancer is the No. 2 cause of cancer-related deaths in the United States, where it claims 51,000 lives a year.
While today's news is certainly good news, let me be clear: It marks the beginning for iCAD, not the end.
As this technology gains wide acceptance -- I think it will become the standard diagnostic protocol nationwide -- iCAD's earnings will soar.
Thousands of hospitals, the vast majority of which already have CT machines or access to them, will adopt iCAD's virtual colonoscopy software. Over the near future, I think iCAD can become a $20 stock.
Action to Take --> Interested investors should not sit on the sidelines, though I'd suggest waiting for a slight pullback, as they often come in the days following a major announcement.
But the reality is I think this is a $20 stock and it is extraordinarily cheap right now given the future of the virtual colonoscopy and the company's very strong other diagnostic divisions.
http://www.istockanalyst.com/article/viewarticle/articleid/4394787
Recent ICAD News
- iCAD to Report First Quarter 2024 Financial Results on May 15, 2024 • GlobeNewswire Inc. • 05/02/2024 12:00:00 PM
- iCAD Showcases New ProFound Cloud, Enhanced ProFound Detection Workstation Features and New Strategic Partnerships at SBI Annual Symposium • GlobeNewswire Inc. • 04/11/2024 12:00:00 PM
- iCAD and Densitas Partner to Enhance Precision Breast Health with Leading AI Solutions for Mammography Quality, Cancer Detection, and Risk Evaluation • GlobeNewswire Inc. • 04/09/2024 12:00:00 PM
- iCAD’s ProFound AI Suite Uncovers Hidden Heart Disease Risk According to New Data Presented at American College of Cardiology Meeting • GlobeNewswire Inc. • 04/08/2024 08:29:22 PM
- iCAD Partners with RAD-AID to Advance Breast Cancer Detection Using AI in Underserved Regions and Low- and Middle-Income Countries (LMICs) • GlobeNewswire Inc. • 04/03/2024 12:00:00 PM
- iCAD Unveils ProFound Cloud, Enabling Interoperability and Access to Breast AI Solutions at Enterprise Scale • GlobeNewswire Inc. • 04/02/2024 12:00:00 PM
- iCAD Releases Enhanced ProFound Detection Workstation Features to Streamline Mammogram Interpretation for Radiologists • GlobeNewswire Inc. • 03/19/2024 01:00:00 PM
- iCAD Announces Fiscal Fourth Quarter and Full-Year 2023 Financial Results • GlobeNewswire Inc. • 03/12/2024 08:01:00 PM
- iCAD Highlights Promising Clinical Data Demonstrating Ability to Reduce Breast Interval Cancer Rates and Decrease Recall Rates at ECR 2024; Showcases Additional Platform Offerings • GlobeNewswire Inc. • 02/28/2024 01:05:00 PM
- iCAD expands Board of Directors with the appointment of Dr. Hedvig Hricak, MD, PhD, (Dr.h.cᵐ) • GlobeNewswire Inc. • 02/27/2024 02:05:00 PM
- iCAD to Report Fourth Quarter and Full Year 2023 Financial Results on March 12, 2024 • GlobeNewswire Inc. • 02/27/2024 01:05:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/26/2024 10:16:15 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/26/2024 10:15:58 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 02/26/2024 10:15:20 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/14/2024 02:00:29 PM
- iCAD to Participate in the BTIG at Snowbird: 11th Annual MedTech, Digital Health, Life Science & Diagnostic Tools Conference • GlobeNewswire Inc. • 02/06/2024 01:00:00 PM
- iCAD Expands Board of Directors with Appointment of Michael J. Doyle, FACHE as New Board Member • GlobeNewswire Inc. • 01/30/2024 01:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/26/2024 12:30:39 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/25/2024 10:15:23 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/17/2024 09:30:32 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/05/2024 01:31:45 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/05/2024 01:31:22 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/05/2024 01:31:05 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/05/2024 01:30:23 AM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM